Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

眼球后段 医学 药物输送 黄斑变性 纳米载体 糖尿病性视网膜病变 药品 眼科 药理学 纳米技术 材料科学 内分泌学 糖尿病
作者
Qi Qi,Yidan Wei,Xin Zhang,Jian Guan,Shirui Mao
出处
期刊:Journal of Controlled Release [Elsevier]
卷期号:361: 191-211 被引量:12
标识
DOI:10.1016/j.jconrel.2023.07.055
摘要

Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vital factor that seriously threatens human vision health and quality of life, the treatment of which poses a great challenge to ophthalmologists and ophthalmic scientists. In particular, ocular posterior drug delivery in a non-invasive manner is highly desired but still faces many difficulties such as rapid drug clearance, limited permeability and low drug accumulation at the target site. At present, many novel non-invasive topical ocular drug delivery systems are under development aiming to improve drug delivery efficiency and biocompatibility for better therapy of posterior segment oculopathy. The purpose of this review is to present the challenges in the noninvasive treatment of posterior segment diseases, and to propose strategies to tackle these bottlenecks. First of all, barriers to ocular administration were introduced based on ocular physiological structure and behavior, including analysis and discussion on the influence of ocular structures on noninvasive posterior segment delivery. Thereafter, various routes of posterior drug delivery, both invasive and noninvasive, were illustrated, along with the respective anatomical obstacles that need to be overcome. The widespread and risky application of invasive drug delivery, and the need to develop non-invasive local drug delivery with alternative to injectable therapy were described. Absorption routes through topical administration and strategies to enhance ocular posterior drug delivery were then discussed. As a follow-up, an up-to-date research advances in non-invasive delivery systems for the therapy of ocular fundus lesions were presented, including different nanocarriers, contact lenses, and several other carriers. In conclusion, it seems feasible and promising to treat posterior oculopathy via non-invasive local preparations or in combination with appropriate devices.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
aaaaarfv完成签到,获得积分10
1秒前
魔幻火龙果完成签到,获得积分10
1秒前
123发布了新的文献求助10
1秒前
李爱国应助周凡淇采纳,获得10
1秒前
情怀应助周凡淇采纳,获得10
2秒前
在水一方应助周凡淇采纳,获得10
2秒前
JamesPei应助周凡淇采纳,获得10
2秒前
小胖发布了新的文献求助30
2秒前
粗心的菀完成签到 ,获得积分10
3秒前
英俊的铭应助希勤采纳,获得10
4秒前
壮观静柏完成签到 ,获得积分10
4秒前
直率的璎发布了新的文献求助30
5秒前
Winner完成签到,获得积分10
5秒前
轩xuan发布了新的文献求助10
5秒前
科研通AI2S应助aaaaarfv采纳,获得10
6秒前
Lucas应助aaaaarfv采纳,获得10
6秒前
完美世界应助简单酒窝采纳,获得10
6秒前
cg完成签到,获得积分10
7秒前
任性的傲柏完成签到,获得积分10
7秒前
SciGPT应助xin采纳,获得10
7秒前
科研牛马完成签到,获得积分10
8秒前
包元霜完成签到,获得积分10
8秒前
嘻嘻完成签到 ,获得积分10
9秒前
apocalypse完成签到 ,获得积分10
9秒前
9秒前
Ava应助xqk采纳,获得10
11秒前
13秒前
max完成签到 ,获得积分10
14秒前
问心发布了新的文献求助10
15秒前
霸气的梦露完成签到,获得积分10
17秒前
寻道图强应助zw采纳,获得50
17秒前
lilili完成签到,获得积分10
18秒前
简单酒窝发布了新的文献求助10
18秒前
狂野的河马完成签到,获得积分10
18秒前
勤奋的松鼠完成签到,获得积分10
19秒前
20秒前
背后的鹭洋完成签到,获得积分10
20秒前
loin完成签到,获得积分10
21秒前
21秒前
淡淡的发卡完成签到,获得积分10
21秒前
高分求助中
The Oxford Handbook of Social Cognition (Second Edition, 2024) 1050
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139867
求助须知:如何正确求助?哪些是违规求助? 2790746
关于积分的说明 7796497
捐赠科研通 2447159
什么是DOI,文献DOI怎么找? 1301623
科研通“疑难数据库(出版商)”最低求助积分说明 626313
版权声明 601185